The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection.

Lo.Li.Pharma

Status: Enrolling

Conditions: HPV Infection

Treatments: Dietary Supplement: EGCG + folic acid + B12

Study type: Interventional

Funder types: Industry

Identifiers

NCT06285357

EPISTOP_22

Details and patient eligibility

About

The purpose of the study is to test the effect of the administration of a dietary supplement consisting of epigallocatechin gallate (EGCG), vitamin B12 and folic acid in the treatment of infections with papilloma virus of the cervix.

Enrollment: 100 estimated patients

Sex: Female

Ages: 25 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• HR-HPV DNA test positivity

Exclusion criteria

• No HSIL

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

100 participants in 2 patient groups

control

No Intervention group

treatment

Experimental group

Treatment:

Dietary Supplement: EGCG + folic acid + B12